Tocilizumab in Covid-19. Reply
N Engl J Med
.
2021 Jan 7;384(1):87.
doi: 10.1056/NEJMc2032911.
Epub 2020 Dec 22.
Authors
John H Stone
1
,
Nora K Horick
1
,
Brian C Healy
1
Affiliation
1
Massachusetts General Hospital, Boston, MA jhstone@mgh.harvard.edu.
PMID:
33356050
DOI:
10.1056/NEJMc2032911
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
COVID-19*
Humans
Receptors, Interleukin-6
SARS-CoV-2
Substances
Antibodies, Monoclonal, Humanized
Receptors, Interleukin-6
tocilizumab